Skip to content
All lessons
Clinical Specialties · Clinical Management

Perioperative Management & Risk Assessment

A Step 2 CK management lesson on perioperative risk assessment for non-cardiac surgery: the ACC/AHA stepwise algorithm, RCRI scoring, the ≥4-MET functional-capacity rule that stops most workups, and evidence-based perioperative medication management (beta-blockers, DAPT/stent timing, anticoagulation bridging, SGLT2/metformin, steroids). Emphasis throughout is the \"next best step\" — optimize and proceed, and test only when it changes management.

13 min readHigh yield

Framing the perioperative question

Perioperative evaluation before non-cardiac surgery is not a pass/fail "clearance" — it is a structured decision to optimize and proceed, delay, or (rarely) cancel. The vast majority of patients proceed to surgery; the exam reward is knowing when not to order more testing.

Four inputs drive every decision:

  1. Urgency — emergency surgery goes to the OR regardless of risk (no time for testing).
  2. Active/unstable cardiac conditions — acute coronary syndrome, decompensated heart failure, unstable arrhythmia, or symptomatic severe valvular disease (esp. severe aortic stenosis) must be evaluated and treated before elective surgery.
  3. Patient risk — quantified with the Revised Cardiac Risk Index (RCRI) or an NSQIP calculator.
  4. Functional capacity — one of the most useful bedside data points.

The core principle (ACC/AHA): order a preoperative stress test only if the result would change management. In a stable patient who can climb two flights of stairs, it will not.

Must-know management rules
  • Emergency surgery → straight to OR. Provide perioperative surveillance and medical optimization; do NOT delay for cardiac stress testing.
  • Screen for unstable cardiac conditions first (ACS, decompensated HF, high-grade/unstable arrhythmia, symptomatic severe AS). Any of these → evaluate/treat before elective surgery.
  • Functional capacity ≥4 METs (climb 2 flights of stairs, walk up a hill, walk ~4 mph) → proceed without further cardiac testing, even if the risk score is "elevated."
  • Stress test only if it changes management — i.e., elevated risk AND poor/unknown functional capacity AND a positive result would lead to revascularization or a changed plan.
  • Do NOT start a beta-blocker on the day of surgery (POISE trial: fewer MIs but MORE strokes and deaths). Continue chronic beta-blockers and continue statins perioperatively.
  • No routine preoperative ECG, CXR, or coagulation panel in asymptomatic patients having low-risk surgery.
  • Don't stop aspirin in a patient with a recent coronary stent; don't bridge every warfarin patient.

ACC/AHA stepwise algorithm (next best step)

StepQuestionIf YES →If NO →
1Is surgery an emergency?Proceed to OR; optimize + surveillanceGo to step 2
2Active/unstable cardiac condition (ACS, decompensated HF, unstable arrhythmia, severe symptomatic valve dz)?Evaluate & treat before elective surgeryGo to step 3
3Estimate perioperative MACE risk (RCRI/NSQIP). Is it low (<1%)?Proceed to surgeryGo to step 4
4Elevated risk: is functional capacity ≥4 METs?Proceed to surgery (no further cardiac testing)Go to step 5
5Poor/unknown capacity: would stress testing change management?Pharmacologic stress test (dobutamine echo / vasodilator MPI)Proceed with medical optimization

Revised Cardiac Risk Index (RCRI / Lee)

#RCRI predictor
1High-risk surgery (intraperitoneal, intrathoracic, or suprainguinal vascular)
2History of ischemic heart disease
3History of congestive heart failure
4History of cerebrovascular disease (stroke/TIA)
5Insulin-treated diabetes mellitus
6Preoperative creatinine >2.0 mg/dL
PointsRisk categoryApprox. MACE
0Low~0.4%
1Low~0.9%
2Elevated~6.6%
≥3Elevated~11%
Vignette — good functional capacity

A 68-year-old man with insulin-treated type 2 diabetes, hypertension, and a prior MI with drug-eluting stent placed 2 years ago is scheduled for elective total hip arthroplasty. He has no chest pain or dyspnea and climbs two flights of stairs to his apartment daily without stopping. Meds: metoprolol, atorvastatin, lisinopril, aspirin, insulin glargine.

Next best step in management?

➡️ Proceed to surgery — no further cardiac (stress) testing.

  • His RCRI = 2 (ischemic heart disease + insulin-treated DM; hip arthroplasty is not an RCRI "high-risk" surgery) → elevated risk, BUT functional capacity ≥4 METs overrides the score and stops the workup.
  • Continue metoprolol and atorvastatin perioperatively (never start/stop a beta-blocker on the day of surgery).
  • Continue aspirin (secondary prevention after prior DES).
  • Hold the morning lisinopril per protocol (intraoperative hypotension) and reduce basal insulin (give ~50–75% of the usual long-acting dose, hold prandial while NPO), targeting glucose 140–180 mg/dL.
  • A pre-op stress test here would be a classic wrong answer — it would not change management.

Perioperative medication management

DrugPerioperative action
Beta-blockerContinue. Do NOT start high-dose the day of surgery (POISE).
StatinContinue. Reasonable to start before vascular surgery.
AspirinContinue with recent coronary stent/high CV risk; otherwise usually hold ~5–7 days (POISE-2: ↑bleeding, no net cardiac benefit for primary prevention).
P2Y12 inhibitor (clopidogrel, etc.)Hold ~5–7 days before elective surgery — UNLESS within the stent DAPT window, in which case delay the surgery instead.
ACE-I / ARBCommonly held the morning of surgery (hypotension); continuation is also reasonable.
WarfarinStop 5 days prior. Bridge with LMWH only if high thrombotic risk (mechanical mitral valve, recent VTE/stroke <3 mo).
DOACStop 1–2 days prior (longer with high bleeding risk or reduced CrCl, esp. dabigatran). No bridging.
MetforminHold the day of surgery (renal/contrast-related lactic acidosis risk).
SGLT2 inhibitorHold 3–4 days before surgery (euglycemic DKA risk).
Chronic glucocorticoidsStress-dose for major surgery if adrenally suppressed (>20 mg prednisone/day for >3 weeks).
Vignette — stent timing vs. elective surgery

A 62-year-old woman had a drug-eluting stent (DES) placed 8 weeks ago for stable angina and is on aspirin + clopidogrel (DAPT). She now requests elective laparoscopic cholecystectomy for recurrent biliary colic.

Next best step in management?

➡️ Postpone the elective surgery until she has completed the recommended DAPT course (ideally ≥6 months after DES), continuing aspirin throughout.

  • Stopping DAPT early is the leading cause of stent thrombosis, which is frequently fatal.
  • Minimum elective-surgery delays after coronary intervention:
  • Balloon angioplasty (no stent): ≥14 days
  • Bare-metal stent: ≥30 days
  • Drug-eluting stent: ideally ≥6 months (3–6 months acceptable only if the surgery cannot wait and ischemic risk is acceptable, via cardiology/surgery discussion).
  • If surgery were truly time-sensitive: proceed with a multidisciplinary plan, continue aspirin (and P2Y12 where feasible), minimizing the interruption.
ASA preoperative fasting — "2-4-6-8"

Minimum NPO times before elective anesthesia (ASA guidelines):

  • 2 hours — clear liquids (water, black coffee, pulp-free juice)
  • 4 hours — breast milk
  • 6 hours — infant formula, non-human milk, and a light meal
  • 8 hours — fried/fatty foods or a heavy (meat) meal

The goal is to minimize gastric volume and aspiration risk on induction.

High-yield pitfalls (the tempting wrong answers)
  • Ordering a stress test when functional capacity is ≥4 METs, or when the result wouldn't change management — the classic distractor.
  • Starting a beta-blocker on the day of surgery — increases stroke/mortality (POISE).
  • Bridging every warfarin patient — bridge only high thrombotic-risk patients (mechanical mitral valve, recent VTE/stroke); routine bridging in AFib increases bleeding without benefit (BRIDGE trial).
  • Forgetting to hold an SGLT2 inhibitor → post-op euglycemic DKA.
  • Stopping aspirin/DAPT and operating within the stent window → stent thrombosis.
  • "Clearing" a patient with unrecognized symptomatic severe aortic stenosis or decompensated HF — these active conditions must be addressed first.
  • Continuing metformin through surgery — hold it the day of the procedure.

Practice Clinical Management now

Board-style questions, spaced-repetition flashcards, and a Socratic AI tutor — free to start.